A chemical genetics approach for the functional assessment of novel cancer genes

Area of Science:

• Molecular biology
• Cancer genetics
• Gene regulation

Background:

• Assessing novel cancer gene function is difficult with current loss-of-function tools.
• Existing methods like RNA interference (RNAi) and genetic knockouts have limitations.
• There is a need for precise tools to study endogenous gene function in cancer.

Purpose of the Study:

• To develop and validate a versatile system for functional characterization of novel cancer genes.
• To address the limitations of current loss-of-function tools.
• To investigate the role of SF3B1 mutations in cancer.

Main Methods:

• Employed TALEN or CRISPR/Cas9 for knock-in of inducible degron tags (Degron-KI).
• Utilized the Degron-KI system for allele-targeted protein inhibition and titration.
• Applied the system to study SF3B1 mutations in cancer cell lines.

Main Results:

• The Degron-KI system allows specific, inducible, and titratable protein depletion.
• This system successfully mimicked pharmacologic inhibition of EZH2 and PI3Kα.
• Established the first causal link between SF3B1 mutations and splicing alterations.
• SF3B1-mutant cells depend on wild-type SF3B1 alleles for growth, not the mutated allele.

Conclusions:

• The Degron-KI system is a versatile tool for functional cancer gene characterization.
• This method overcomes limitations of existing loss-of-function approaches.
• The study provides critical insights into SF3B1 function and its role in cancer.